We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$401M
AUM Growth
-$49.1M
Cap. Flow
-$51.9M
Cap. Flow %
-12.95%
Top 10 Hldgs %
77.61%
Holding
82
New
5
Increased
1
Reduced
3
Closed
2
Avg Time Held
2.6 years
Top 10 Avg Time Held
2.4 years
Top 20 Avg Time Held
2.2 years

Top Buys

Rank Stock Value
1
IMMX icon
Immix Biopharma
IMMX
+$3.29M
2
CUE icon
Cue Biopharma
CUE
+$2.35M
3
MODD icon
Modular Medical
MODD
+$1.25M
4
IPWR icon
Ideal Power
IPWR
+$1.2M
5
TALK icon
Talkspace
TALK
+$680K

Top Sells

Rank Stock Value
1
BC icon
Brunswick
BC
+$48.4M
2
LIN icon
Linde
LIN
+$11M
3
BLUE icon
bluebird bio
BLUE
+$1.87M
4
SLGCW
SomaLogic, Inc. Warrant
SLGCW
+$1.68K
5
FAZEW
FaZe Holdings Inc. Warrant
FAZEW
+$323

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.85%
2 Healthcare 21.24%
3 Industrials 16.95%
4 Materials 10.55%
5 Consumer Discretionary 10.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BLUE icon
26
DELISTED
bluebird bio
BLUE
$1.33M 0.33%
51,869
-73,131
-59% -$1.87M
2023 Q3
2 quarters
MODD icon
27
Modular Medical
MODD
$19.8M
$1.29M 0.32%
+23,333
New +$1.25M
2024 Q1
0 quarters
SPY icon
28
State Street SPDR S&P 500 ETF Trust
SPY
$813B
$1.29M 0.32%
2,470
– –
2023 Q4
1 quarter
LBTYK icon
29
Liberty Global Class C
LBTYK
$2.72B
$1.23M 0.31%
69,618
– –
2019 Q4
17 quarters
IPWR icon
30
Ideal Power
IPWR
$52.4M
$1.18M 0.3%
+133,000
New +$1.2M
2024 Q1
0 quarters
PROF icon
31
Profound Medical
PROF
$238M
$1.14M 0.28%
133,333
– –
2023 Q4
1 quarter
MXCT icon
32
MaxCyte
MXCT
$131M
$1.08M 0.27%
250,000
– –
2021 Q3
10 quarters
TALK icon
33
DELISTED
Talkspace
TALK
$893K 0.22%
+250,000
New +$680K
2024 Q1
0 quarters
RCAT icon
34
Red Cat Holdings
RCAT
$736M
$765K 0.19%
1,000,000
– –
2023 Q4
1 quarter
ONDS icon
35
Ondas Inc
ONDS
$3.64B
$752K 0.19%
775,000
– –
2021 Q3
10 quarters
LSXMA icon
36
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$719K 0.18%
24,197
– –
2020 Q2
15 quarters
DMAC icon
37
DiaMedica Therapeutics
DMAC
$423M
$616K 0.15%
222,317
– –
2023 Q2
3 quarters
LLYVK icon
38
Liberty Live Group Series C
LLYVK
$9.22B
$605K 0.15%
13,802
– –
2023 Q3
2 quarters
RTX icon
39
RTX Corp
RTX
$252B
$585K 0.15%
6,000
– –
2020 Q2
15 quarters
ICCC icon
40
ImmuCell
ICCC
$97.8M
$538K 0.13%
101,594
– –
2021 Q2
11 quarters
EVOK icon
41
DELISTED
Evoke Pharma
EVOK
$503K 0.13%
+68,750
New +$584K
2024 Q1
0 quarters
LBTYA icon
42
Liberty Global Class A
LBTYA
$2.75B
$389K 0.1%
22,989
– –
2019 Q4
17 quarters
PYPL icon
43
PayPal
PYPL
$48.2B
$355K 0.09%
5,300
– –
2020 Q1
16 quarters
CARR icon
44
Carrier Global
CARR
$45.1B
$349K 0.09%
6,000
– –
2020 Q2
15 quarters
LHX icon
45
L3Harris
LHX
$44.7B
$341K 0.09%
1,600
– –
2019 Q4
17 quarters
OTIS icon
46
Otis Worldwide
OTIS
$26.6B
$298K 0.07%
3,000
– –
2020 Q2
15 quarters
CRIS icon
47
Curis
CRIS
$1.47M
$272K 0.07%
1,250
– –
2020 Q4
13 quarters
LLYVA icon
48
Liberty Live Group Series A
LLYVA
$8.93B
$256K 0.06%
6,047
– –
2023 Q3
2 quarters
PHYS icon
49
Sprott Physical Gold
PHYS
$14.9B
$217K 0.05%
12,540
– –
2019 Q4
17 quarters
GPCR icon
50
Structure Therapeutics
GPCR
$1.57B
$214K 0.05%
5,000
– –
2023 Q4
1 quarter
1
2
3 4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2024 Portfolio in Review

As of Q1 2024, Bleichroeder LP held 82 positions worth $401M, down 11% from $450M the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Bleichroeder LP withdrew a net $51.9M in Q1 2024, closing 2 positions and reducing 3 holdings. Its most notable exit was SomaLogic, Inc. Warrant, an estimated $1.68K position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Bleichroeder LP opened a new position in Immix Biopharma worth $2.61M.

  • Bleichroeder LP's largest Q1 2024 buy was Immix Biopharma: 850,000 shares worth $2.61M.
  • Bleichroeder LP added most to Cue Biopharma in Q1 2024, an estimated $2.35M increase.
  • Bleichroeder LP's biggest Q1 2024 reduction was Brunswick, cutting an estimated $48.4M.
  • Bleichroeder LP fully exited SomaLogic, Inc. Warrant in Q1 2024, selling an estimated $1.68K.
  • Bleichroeder LP's ten largest holdings make up 78% of its $401M portfolio in Q1 2024.
  • Bleichroeder LP opened 5 new positions and closed 2 in Q1 2024.
  • Bleichroeder LP's portfolio value fell 11% quarter-over-quarter to $401M.

Based on Bleichroeder LP's 13F filing for Q1 2024, filed 14 May 2024.